NCT05109156

Brief Summary

Preoperative sepsis timeline, profile and its association with recipient outcome following live donor liver transplant.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

November 5, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

November 5, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

January 26, 2022

Status Verified

October 1, 2021

Enrollment Period

3 months

First QC Date

October 20, 2021

Last Update Submit

January 13, 2022

Conditions

Keywords

SepsisLive donor liver transplant(LDLT),Liver capsular macrophages(LCM)Peritoneal macrophages(PM)

Outcome Measures

Primary Outcomes (1)

  • Correlation of timeline of sepsis with recipient outcome following Live donor liver transplant.

    a. Post-operative sepsis b. In hospital mortality c. Hospital stay d. ICU stay e. Retransfer to ICU f. Days on ventilator g. Need for tracheostomy/re-intubation h Duration of inotropic support

    30 days

Secondary Outcomes (1)

  • study the correlation between recipient liver capsular and peritoneal macrophage activity and preoperative sepsis timeline, profile as well as post operative recipient outcome.

    30 days

Study Arms (1)

This is an observational study

This is an observational study

Other: This is an observational study

Interventions

This is an observational study

This is an observational study

Eligibility Criteria

AgeUp to 70 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing/ undergone live donor liver transplant at our institute

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Liver and Biliary Sciences

New Delhi, National Capital Territory of Delhi, 110070, India

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Explant liver with be sent for assessment of the subcapsular layer in addition to routine Histo pathological examination (HPE). 20 ml of peritoneal fluid from the recipient will also be collected and processed for analysis of peritoneal macrophages. Samples will then be subjected to flow cytometry for assessment of: 1. Macrophage identification markers: Quantitative assessment . 2. Macrophage Activation markers: Qualitative/ Activation assessment. Density and functionality of both LCM and PM will then be co-related to both pre-LT sepsis timeline and profile as well as post operative recipient outcome . Identification of Macrophage populations using Flow Cytometry and Immunohistochemistry

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Viniyendra Pamecha, FEBS

    Institute of Liver & Biliary Sciences

    STUDY DIRECTOR

Central Study Contacts

Bharat Nair, MBBS, MS,MRCS

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 20, 2021

First Posted

November 5, 2021

Study Start

November 5, 2021

Primary Completion

February 1, 2022

Study Completion

April 1, 2022

Last Updated

January 26, 2022

Record last verified: 2021-10

Locations